Analysts think PFE stock price could increase by 18%
Jun 03, 2025, 11:25 AM
6.96%
What does PFE do
Pfizer, a global biopharmaceutical company headquartered in New York City, employs 88,000 people and focuses on discovering, developing, and distributing oncology, primary care, and specialty care products worldwide. Key products include Ibrance, Eliquis, and Xeljanz, among others.
24 analysts think PFE stock price will increase by 17.54%. The current median analyst target is $27.54 compared to a current stock price of $23.43. The lowest analysts target is $23.23 and the highest analyst target is $43.56.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.